1. Home
  2. YDDL vs BCYC Comparison

YDDL vs BCYC Comparison

Compare YDDL & BCYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

YDDL

One and One Green Technologies. Inc Class A Ordinary Shares

HOLD

Current Price

$2.09

Market Cap

358.9M

ML Signal

HOLD

Logo Bicycle Therapeutics plc

BCYC

Bicycle Therapeutics plc

HOLD

Current Price

$4.34

Market Cap

296.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
YDDL
BCYC
Founded
2014
2009
Country
Philippines
United Kingdom
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
358.9M
296.0M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
YDDL
BCYC
Price
$2.09
$4.34
Analyst Decision
Buy
Analyst Count
0
10
Target Price
N/A
$13.90
AVG Volume (30 Days)
32.9K
647.2K
Earning Date
04-27-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$40.85
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.95
$3.92
52 Week High
$16.23
$9.18

Technical Indicators

Market Signals
Indicator
YDDL
BCYC
Relative Strength Index (RSI) 26.24 56.05
Support Level N/A $4.25
Resistance Level $3.03 $4.75
Average True Range (ATR) 0.27 0.17
MACD 0.03 0.05
Stochastic Oscillator 13.02 90.53

Price Performance

Historical Comparison
YDDL
BCYC

About YDDL One and One Green Technologies. Inc Class A Ordinary Shares

One and one Green Technologies Inc is engaged in recycling, production, and trading of recycled scrap metals in the Republic of Philippines. The company process raw materials and generate final products that include copper alloy ingot, aluminum scrapes, plastic beads, and others. It provides economical and flexible solutions to the challenges of electronic waste, metal scrap and industrial recycling. By providing lower-cost alternatives for processing recycled materials, It is not only Contributing to environmental sustainability but also highlight its role as a modern and specialized recycling company.

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United Kingdom.

Share on Social Networks: